We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ocular Sciences (OCLR)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: EyeDrMike who wrote (17)6/15/1999 11:15:00 AM
From: Alan Villalon   of 36
Short term and day traders are always near sighted.

The article just confirms what I said in my previous post. People reacted too hastily once they fear that momentum will dissipate. One of the things I also liked when looking at OCLR was their long term debt. I usually pick companies with very little long term debt because they can 1. take on debt in the future to fuel more growth 2. look more attractive in M&A deals 3. no interest payments on debt so there is little influence on earnings.

We have probably seen the last of investors like Dragonpawn in OCLR. If management does the right things, the people who will benefit the most are the long term investor.

Remember, long term and patient investors always benefit the most over time. In the era of day trading, people have forgotten to invest like the Buffet's and Peter Lynch's. Buy to own a company! Just my style, I prefer to know that I invested in an solid company and get more sleep at night rather than toss and turn at every earnings announcement and press release. People forget that it is natural for every facet of life to have its ups and downs.

Just my 2 cents worth....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext